Plain-English translation of NCT05295498 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a noninvasive treatment called repetitive transcranial magnetic stimulation (rTMS) for people with chronic nerve pain that doesn't respond well to pain medications. The treatment uses magnetic pulses applied to your scalp to stimulate specific areas of your brain, which may help reduce pain signals. This trial is testing whether delivering multiple sessions over a short period—called 'accelerated' treatment—can safely and effectively ease neuropathic pain.
Nerve pain from peripheral neuropathy is common but often doesn't respond well to standard pain medications. While this magnetic brain stimulation has shown promise for treating depression and other conditions, researchers want to see if it can safely and effectively reduce chronic nerve pain when given in multiple sessions over just a few days.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you'll receive six sessions of magnetic brain stimulation—three sessions given on each of two consecutive days. During each session, a magnetic coil is placed against your scalp over the motor area of your brain, and you'll receive 1,500 magnetic pulses. Some participants will receive the active treatment, while others will receive sham (placebo) stimulation that feels similar but doesn't deliver the therapeutic magnetic field. The entire treatment course takes place over just two days.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Poland